CN110551037A - Method for catalyzing asymmetric hydrogenation of imine by iridium/chiral diphosphine system - Google Patents

Method for catalyzing asymmetric hydrogenation of imine by iridium/chiral diphosphine system Download PDF

Info

Publication number
CN110551037A
CN110551037A CN201810547260.9A CN201810547260A CN110551037A CN 110551037 A CN110551037 A CN 110551037A CN 201810547260 A CN201810547260 A CN 201810547260A CN 110551037 A CN110551037 A CN 110551037A
Authority
CN
China
Prior art keywords
iridium
chiral
imine
asymmetric hydrogenation
chiral diphosphine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810547260.9A
Other languages
Chinese (zh)
Other versions
CN110551037B (en
Inventor
胡向平
胡信虎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Institute of Chemical Physics of CAS
Original Assignee
Dalian Institute of Chemical Physics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Institute of Chemical Physics of CAS filed Critical Dalian Institute of Chemical Physics of CAS
Priority to CN201810547260.9A priority Critical patent/CN110551037B/en
Publication of CN110551037A publication Critical patent/CN110551037A/en
Application granted granted Critical
Publication of CN110551037B publication Critical patent/CN110551037B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2282—Unsaturated compounds used as ligands
    • B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/06—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60—Reduction reactions, e.g. hydrogenation
    • B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/643—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of R2C=O or R2C=NR (R= C, H)
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0225—Complexes comprising pentahapto-cyclopentadienyl analogues
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/827—Iridium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/84—Metals of the iron group
    • B01J2531/842—Iron
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

the invention discloses an asymmetric hydrogenation method of imine catalyzed by an iridium/chiral diphosphine system, which takes chiral diphosphine ligand and metal iridium precursor to react to prepare a complex in situ as a catalyst, and imine is asymmetrically hydrogenated to prepare chiral amine. The ligand of the invention has simple preparation, low catalyst consumption, simple and convenient operation, can realize continuous operation, is suitable for preparing chiral amine on a large scale, has the enantiomeric excess value of more than 80 percent, has better result for 500000 of 2-ethyl-6-methylaniline/catalyst (S/C) in the synthesis of the metolachlor intermediate, achieves 95 percent of yield and 91 percent of enantioselectivity, and has good industrial practicability.

Description

Method for catalyzing asymmetric hydrogenation of imine by iridium/chiral diphosphine system
Technical Field
The invention belongs to the field of organic synthesis, and particularly relates to an asymmetric hydrogenation method for imine by using an iridium/chiral diphosphine system as a catalyst.
Background
Chiral amine compounds are important organic synthetic intermediates useful in the preparation of a variety of natural and unnatural compounds having biological activity. In recent years, the preparation of chiral amine compounds by asymmetric catalytic Hydrogenation of imines has been very successful [ (a) H. -U.Blaser, F.Spinder in Handbook of Homogeneous Hydrogenation (eds.: J.G.de Vries, C.J.Elsevier), Wiley-VCH, Weinheim,2007, pp.1193; (b) claver, e.fernandez in Morden Reduction Methods (eds.: p.anderson, i.munsell), Wiley-VCH, Weinheim,2008, pp.237; (c) U.Blaser, F.Spinder in Comprehensive asymmetry catalysis catalysts (eds.: E.Jacobsen, A.Pfaltz, H.Yamamoto), Springer, Berlin,1999, pp.247 ], but the catalytic systems have the problems of low reaction activity, narrow substrate range, harsh reaction conditions and the like, and particularly, for the synthetic route of obtaining the refined metolachlor through asymmetric catalysis, a plurality of different attempts are made by organic chemists at home and abroad to design and synthesize a plurality of asymmetric catalytic catalysts. The preparation of s-metolachlor intermediates by asymmetric hydrogenation of (2-methyl-6-ethylaniline) -imines was found to be a viable and efficient route.
In 1975, Levi et al reported a hydrogenation process for imines, but the enantiomeric excess (ee value) was only 22% (Levi A., Modena G., Scorano G.J.chem.Soc.Commun.1975,1, 6-7). In 1999, Hans-PeterJalett et al catalyzed asymmetric hydrogenation with ferrocene bisphosphine ligand increased its ee value to 76% (Jalett H.P., Spindler F., Hanreich R.G.US5886225[ P ],1999) and achieved industrialization. The method is characterized in that { (R) -1- [ (S) -2-diphenylphosphine cyclopentadienyl iron group ] } ethyl-bis- (3, 5-dimethylphenyl) phosphine is used as a ligand and forms a catalyst precursor with an iridium complex in situ, and the asymmetric hydrogenation of 2-methyl-6-ethyl-N-methyleneaniline is catalyzed in the presence of acid and tetrabutylammonium iodide at 50 ℃ and 80 atmospheres of hydrogen pressure to obtain chiral amine with the highest ee of 76%. However, the synthesis of the ligand used in this reaction is difficult, and the hydrogenation system requires a large amount of acid and requires high equipment. Therefore, the development of the catalyst for preparing the chiral amine with high activity, high stereoselectivity and low cost has very important significance.
disclosure of Invention
The invention aims to provide a method for catalyzing asymmetric hydrogenation of imine by an iridium/chiral diphosphine system.
In order to achieve the purpose, the technical scheme of the invention is as follows:
An asymmetric hydrogenation method of imine catalyzed by iridium/chiral diphosphine system, which adopts chiral catalyst Ir-L to prepare chiral amine by asymmetric hydrogenation of imine; the chiral catalyst Ir-L is generated by in-situ coordination of an iridium-cyclooctadiene complex and a chiral diphosphine ligand in a solvent.
An asymmetric hydrogenation method of imine catalyzed by an iridium/chiral diphosphine system comprises the following steps:
(1) adding an iridium-cyclooctadiene complex and a chiral diphosphine ligand into the solvent, stirring the mixture for 2 to 5 hours at room temperature, and carrying out in-situ coordination to generate a chiral catalyst Ir-L;
(2) Under the protection of nitrogen, adding a substrate imine dissolved in a solvent, adding a chiral catalyst Ir-L, placing the mixture into a high-pressure reaction kettle, performing hydrogen replacement for 3 times, introducing hydrogen to 20-100bar, reacting at 20-100 ℃ for 1-24 hours, slowly releasing the hydrogen, removing the solvent, and separating by using a silica gel column to obtain a product chiral amine;
the solvent is dichloromethane, 1, 2-dichloroethane or toluene;
the substrate imine is as follows:
R1Is C1～C10Alkyl radicals such as CH3、CH3CH2Etc. C3～C12cycloalkyl radicals such as cyclopentyl, cyclohexyl, etc., or C containing one or more functional groups of N, S, O, P1～C10Alkyl such as methoxymethyl, ethoxymethyl, etc., or C containing one or more functional groups of N, S, O, P3～C10cycloalkyl groups such as 2-tetrahydrofuryl, 4-tetrahydrofuryl, etc.; or aryl or the like C6-C30Aromatic groups such as phenyl, 4-methoxyphenyl, etc., which may or may not contain N, S, O, P, etc.; or ester groups such as COOCH3、COOCH2CH3Etc.;
R2Is H, C1-C40Alkyl or aryl within;
in order to achieve the purpose, the technical scheme of the invention is as follows:
the imines and the chiral amines produced according to the invention have the following structures:
in the formula:
R1Is C1～C10Alkyl radicals such as CH3、CH3CH2etc. C3～C12Cycloalkyl radicals such as cyclopentyl, cyclohexyl, etc., or C containing one or more functional groups of N, S, O, P1～C10alkyl such as methoxymethyl, ethoxymethyl, etc., or C containing one or more functional groups of N, S, O, P3～C10cycloalkyl groups such as 2-tetrahydrofuryl, 4-tetrahydrofuryl, etc.; or aryl or the like C6-C30aromatic groups such as phenyl, 4-methoxyphenyl, etc., which may or may not contain N, S, O, P, etc.; or ester groups such as COOCH3、COOCH2CH3Etc.;
R2Is H, C1-C40alkyl or aryl within;
Ar is C such as phenyl, 2-substituted, 3-substituted, 4-substituted, 2, 6-disubstituted, 2,4, 6-trisubstituted aryl, etc6-C30Aromatic groups containing or not containing N, S, O, P functional groups such as 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 2-methyl-6-ethylphenyl, thiophene, etc.
The structural general formula of the chiral diphosphine ligand L is as follows:
wherein: r is one of phenyl, substituted phenyl, alkyl or cycloalkyl, and R' is one of phenyl, substituted phenyl, alkyl, hydrogen, halogen or cycloalkyl.
The iridium-cyclooctadiene complex is: [ Ir (COD) Cl]2、Ir(COD)2BF4Or Ir (COD)2BARF。
the iridium concentration in the reaction system is 0.0001-0.01mol/l, and the molar ratio of the ligand to the iridium is 1-5: 1.
the molar ratio of the imine substrate to the catalyst is 100-500000: 1.
The ligand synthesis method related by the invention is shown as the following reaction equation:
The preparation method of the chiral diphosphine ligand L comprises the following steps:
(1) introducing argon to react (R)c,Sp) -ppfa (i) and imidazole are dissolved in dehydroacetic acid and heated to 80 ℃ for 8 hours; (R)c,Sp) The molar ratio of PPFA (I) to imidazole is 1: 1.1-5;
Cooling, neutralizing with excessive saturated sodium bicarbonate solution, extracting with dichloromethane (3 × 50ml), mixing organic phases, washing with saturated saline solution, drying with anhydrous sodium sulfate, removing solvent, and subjecting the crude product to column chromatography (n-hexane/ethyl acetate/triethylamine: 10/10/1); brown crystals II;
(2) Under the condition of introducing argon, dissolving the brown crystal II in diethyl ether, slowly dropwise adding n-BuLi, gradually changing the reaction mixture into a dark red clear solution, and continuously reacting for one hour; dropwise adding diphenyl phosphine chloride, wherein the molar ratio of the brown crystal II, the n-BuLi and the diphenyl phosphine chloride is 1: 1.2-5;
after reacting for two hours, a saturated sodium hydrogencarbonate solution was added, and the organic phase was separated, washed with saturated brine and dried over anhydrous sodium sulfate. Desolventizing, column chromatography (n-hexane/ethyl acetate 10/1), and n-hexane recrystallization to give 0.24g of orange needle crystals Ianamely chiral diphosphine ligand L.
the invention has the beneficial effects that: compared with other methods for synthesizing chiral amine, the method for synthesizing chiral diphosphine ligand L by imine reductive hydrogenation is simple in synthesis, low in price and suitable for kilogram-level production, an iridium/chiral diphosphine system is high in catalytic activity and enantioselectivity, the enantiomeric excess value (ee value) of a product reaches more than 85%, the reductive amination reaction is simple to operate, mild in conditions and high in atom economy, and the method is suitable for industrial production, has a good result that 2-ethyl-6-methylaniline/a catalyst (S/C) is 500000 in the synthesis of the S-metolachlor intermediate, achieves 95% of yield and 91% of enantioselectivity, and has good industrial practicability.
Detailed Description
The following examples further illustrate the invention but are not intended to limit the invention thereto. NMR was measured by Bruker NMR and High Performance Liquid Chromatography (HPLC) was measured by Agilent1100 series HPLC. GC analysis conditions were as follows: SE-54, injection port temperature: 250 degrees, detector temperature: initial temperature 50 ℃ for 2 minutes, then 10 ℃ per minute to 250 ℃ and then 5 minutes.
Example 1
The ligand synthesis method related by the invention is shown as the following reaction equation:
Wherein (R)c,Sp)-Ia:R＝Me,R＇＝H；(Rc,Sp)-Ib:R＝Et,R＇＝H；(Rc,Sp)-Ic:R＝Ph,R＇＝H etc
1 preparation of ligand (R)c,Sp)-Ia
Introducing argon, adding 1.32g of (R)c,Sp) PPFA (I) and 1.63g imidazole were dissolved in 15ml dehydroacetic acid and heated to 80 ℃ for 8 hours. After cooling, the reaction mixture was neutralized with an excess of saturated sodium bicarbonate solution, extracted with dichloromethane (3 × 50ml), the organic phases were combined, washed with saturated brine, dried over anhydrous sodium sulfate, desolventized and the crude product was subjected to column chromatography (n-hexane/ethyl acetate/triethylamine ═ 10/10/1) to give 1.24g of brown crystals II in 89% yield.
0.23g of II was dissolved in 15ml of dry diethyl ether under argon and 0.47ml of n-BuLi was slowly added dropwise, the reaction mixture gradually turned into a deep red clear solution and the reaction was continued for one hour. 0.13ml of diphenylphosphine chloride was added dropwise thereto, the reaction was carried out for two hours, a saturated sodium hydrogencarbonate solution was added thereto, the organic phase was separated, washed with saturated brine and dried over anhydrous sodium sulfate. Desolventizing, column chromatography (n-hexane/ethyl acetate 10/1), and n-hexane recrystallization to give 0.24g of orange needle crystals Iathe yield thereof was found to be 75%.
nuclear magnetic resonance spectroscopy data for the ligands are as follows:
1H NMR(400MHz,CDCl3):δ7.53(m,4H),7.33-7.38(m,5H),7.25(s,1H),7.15(m,3H),7.07(m,3H),6.92(m,3H),6.78(d,J＝2.0Hz,4H),6.57(m,2H),6.43(m,1H),4.69(s,1H),4.43(s,1H),4.06(s,5H),3.91(s,1H),1.62(d,J＝6.8Hz,1H),ppm；31P NMR(162MHz，CDCl3):δ-24.12,-35.12ppm；13C NMR(100MHz,CDCl3):δ143.7,139.0,137.6,36.2,135.5,134.4,133.4,131.4,130.7,129.2,128.5,128.2,128.0,127.9,127.7,127.4,118.9,93.8,76.5,72.1,70.1,70.0,69.3,51.2,23.0ppm。
Upon detection, the ligand (R)c,Sp)-IaThe structural formula of (A) is as follows:
2 preparation of ligand (R)c,Sp)-Ib
(Rc,Sp)-Ibaccording to (R)c,Sp)-IaThe method of (1).
Nuclear magnetic resonance spectroscopy data for the ligands are as follows:
1H NMR(400MHz,CDCl3):δ7.57(m,4H),7.4(m,3H),7.20-7.27(m,5H),7.08-7.14(m,3H),7.00(t,J＝6.8Hz,2H),6.86-6.92(m,3H),6.37(t,J＝7.0Hz,2H),6.21(br,1H),4.66(br,1H),4.38(s,1H),3.98(s,5H),3.91(s,1H),2.52(m,1H),2.04(br,1H),0.62(m,3H)ppm；31P NMR(162MHz，CDCl3):δ-23.86,-37.95ppm；13C NMR(100MHz,CDCl3):δ144.8,139.6,138.0,137.0,136.6,135.8,135.5,134.5,134.3,133.8,133.6,131.3,131.2,129.4,128.7,128.3,128.2,128.1,128.0,127.9,127.6,127.1,119.0,94.9,76.3,72.2,70.0,57.1,29.6,11.6ppm。
detected, ligand IbThe structural formula of (A) is as follows:
3 preparation of ligand (R)c,Sp)-Ic
(Rc,Sp)-IcAccording to (R)c,Sp)-IaThe method of (1).
nuclear magnetic resonance spectroscopy data for the ligands are as follows:
1H NMR(400MHz,CDCl3):δ7.60(m,2H),7.45(m,1H),7.36(m,5H),7.15(m,8H),7.04(m,2H),6.97(m,4H),6.89(m,3H),6.82(m,3H),4.42(s,1H),4.39(s,1H),4.05(s,1H),3.85(s,5H)ppm；31P NMR(162MHz，CDCl3):δ-25.30,-33.55ppm；13C NMR(100MHz,CDCl3):δ144.7,139.9,138.3,137.4,135.6,135.3,133.6,133.4,132.0,130.2,129.3,128.2,128.1,128.0,127.9,127.8,127.7 127.6,120.2,92.8,72.6,71.1,70.4,70.2,59.8,59.6ppm。
The structural formula of the ligand is detected as follows:
preparation of 4 catalyst Ir-I
0.6717g of a metal precursor [ Ir (COD) Cl was added]2And 1.690g of ligand I is stirred in 2L of dichloroethane at room temperature for 2h to generate the catalyst (10)-3mol/l)。
example 2
the hydrogenation reaction was carried out in a 200ml autoclave. The reaction kettle is replaced by nitrogen for three times, then 52g of imine (generated by 2-methyl-6-ethyl aniline and methoxy acetone) is injected into the reaction kettle, and 0.5ml of catalyst which is well coordinated in situ is injected into the reaction kettleReagent Ir-Ia(S/C＝5×105). And then replacing with hydrogen for three times, introducing hydrogen, pressurizing to 50bar, heating to 80 ℃, reacting for 3 hours, cooling, relieving pressure, opening the kettle, performing GC analysis to obtain 50g of (S) -NAA, wherein the reaction conversion rate is more than 99%, and performing reduced pressure distillation to obtain 50g of (S) -NAA, the yield is 95%, and the ee value of HPLC analysis is 91%.
Liquid phase and nmr spectra data were as follows:
HPLC(OJ-H,n-hexane/i-PrOH＝98/2,1.0ml/min,254nm,40℃):tR(minor)＝3.9min,tR(major)＝4.3min.1H NMR(400MHz,CDCl3):7.02(dd,J＝7.6,15.2Hz,2H),6.89(t,J＝7.6Hz,1H),3.36-3.40(m,6H),2.67(q,J＝7.6Hz,2H),2.31(s,3H),1.25(t,J＝7.6Hz,3H),δ＝1.20(d,J＝5.6Hz,3H)ppm。
the product was presumed to be (S) -2-ethyl-N- (1-methoxy-2-propyl) -6-methylaniline, and the structural formula was as follows:
Example 3
otherwise the catalyst Ir-I was identical to example 2aModified to Ir-IbThe reaction conversion rate was more than 99% by GC analysis and the ee value was 85% by HPLC analysis.
example 4
Otherwise the catalyst Ir-I was identical to example 2aModified to Ir-IcThe reaction conversion rate was more than 99% by GC analysis and the ee value was 80% by HPLC analysis.
Example 5
Otherwise, the reaction pressure was 80bar, the reaction conversion was greater than 99% by GC analysis and the ee value by HPLC analysis was 90% as in example 2.
Example 6
Otherwise, the reaction pressure was 60bar, the reaction conversion was greater than 99% by GC analysis and the ee value by HPLC analysis was 91% as in example 2.
example 7
otherwise the reaction temperature was 100 ℃ and the reaction conversion was more than 99% by GC analysis and 88% by HPLC analysis under the same conditions as in example 2.
Example 8
Otherwise conditions were the same as in example 2, molar ratio of substrate to catalyst (S/C ═ 106) The reaction conversion was 90% by GC analysis and the ee value was 89% by HPLC analysis.
example 9
Otherwise conditions were the same as in example 2, modified to ligand Ibthe reaction conversion was 15% by GC analysis and the ee value was 10% by HPLC analysis.
Example 10
Otherwise conditions were the same as in example 2, modified to ligand IcThe reaction conversion was 99% by GC analysis and the ee value by HPLC analysis was 94%.
Example 11
the substrate in the example 2 is changed into 2- (2, 6-dimethylphenylimino) methyl propionate, and the reaction is carried out in the same way as the example 2 to obtain the product 2- (2, 6-dimethylphenylamino) methyl propionate. 96% yield.86% ee.
Liquid phase and nmr spectra data were as follows:
HPLC(chiralcel OD-H,n-hexane/i-PrOH＝99/1,1.0ml/min,254nm,40℃):tR(minor)＝6.9min,tR(major)＝7.7min.1H NMR(400MHz,CDCl3):δ＝6.97(d,J＝7.6Hz,2H),6.81(t,J＝7.6Hz,1H),4.00(q,J＝7.2Hz,1H),3.68(s,3H),2.31(s,6H)，1.38(d,J＝7.2Hz,3H)。
The product was presumed to be methyl 2- (2, 6-dimethylphenylamino) propionate, of the formula:

Claims (8)

1. An asymmetric hydrogenation method of imine catalyzed by an iridium/chiral diphosphine system is characterized in that: the method adopts a chiral catalyst Ir-L, and adopts imine asymmetric hydrogenation to prepare chiral amine; the chiral catalyst Ir-L is generated by in-situ coordination of an iridium-cyclooctadiene complex and a chiral diphosphine ligand in a solvent.
2. The method for the asymmetric hydrogenation of imine by using an iridium/chiral diphosphine system according to claim 1, wherein the method comprises the following steps: the method specifically comprises the following steps:
(1) Adding an iridium-cyclooctadiene complex and a chiral diphosphine ligand into the solvent, stirring the mixture for 2 to 5 hours at room temperature, and carrying out in-situ coordination to generate a chiral catalyst Ir-L;
(2) Under the protection of nitrogen, adding a substrate imine dissolved in a solvent, adding a chiral catalyst Ir-L, placing the mixture into a high-pressure reaction kettle, performing hydrogen replacement for 3 times, introducing hydrogen to 20-100bar, reacting at 20-100 ℃ for 1-24 hours, slowly releasing the hydrogen, removing the solvent, and separating by using a silica gel column to obtain a product chiral amine;
The solvent is dichloromethane, 1, 2-dichloroethane or toluene;
The substrate imine is as follows:
R1Is C1～C10Alkyl radicals such as CH3、CH3CH2etc. C3～C12Cycloalkyl radicals such as cyclopentyl, cyclohexyl, etc., or C containing one or more functional groups of N, S, O, P1～C10Alkyl such as methoxymethyl, ethoxymethyl, etc., or C containing one or more functional groups of N, S, O, P3～C10Cycloalkyl groups such as 2-tetrahydrofuryl, 4-tetrahydrofuryl, etc.; or aryl or the like C6-C30Aromatic groups such as phenyl, 4-methoxyphenyl, etc., which may or may not contain N, S, O, P, etc.; or ester groups such as COOCH3、COOCH2CH3etc.;
R2Is H, C1-C40Alkyl or aryl within.
3. The method for the asymmetric hydrogenation of imines catalyzed by an iridium/chiral diphosphine system according to claim 1 or 2, characterized in that; the imine and the resulting chiral amine have the following structures:
In the formula: r1Is C1～C10Alkyl radical, C3～C12Is cycloalkyl, or C containing one or more functional groups of N, S, O, P1～C10Alkyl, or C containing one or more functional groups of N, S, O, P3～C10a cycloalkyl group; or C6-C30Aromatic groups with or without N, S, O, P functional groups; or an ester group;
R2is H, C1-C40Alkyl or aryl within;
Ar is phenyl, 2-substituted, 3-substituted, 4-substituted, 2, 6-disubstituted, 2,4, 6-trisubstituted aryl and C6-C30Aromatic groups with or without N, S, O, P functional groups.
4. the method for the asymmetric hydrogenation of imines catalyzed by an iridium/chiral diphosphine system according to claim 1 or 2, wherein: the chiral diphosphine ligand L has the following structural general formula:
Wherein: r is one of phenyl, substituted phenyl, alkyl or cycloalkyl, and R' is one of phenyl, substituted phenyl, alkyl, hydrogen, halogen or cycloalkyl.
5. The method for the asymmetric hydrogenation of imines catalyzed by an iridium/chiral diphosphine system according to claim 1 or 2, wherein: the iridium-cyclooctadiene complex is: [ Ir (COD) Cl]2、Ir(COD)2BF4or Ir (COD)2BARF。
6. The method for the asymmetric hydrogenation of imine by using an iridium/chiral diphosphine system according to claim 2, wherein the method comprises the following steps: the iridium concentration in the reaction system is 0.0001-0.01mol/L, and the molar ratio of the ligand to the iridium is 1-5: 1.
7. The method for the asymmetric hydrogenation of imine by using an iridium/chiral diphosphine system according to claim 2, wherein the method comprises the following steps: the molar ratio of the imine substrate to the chiral catalyst Ir-L is 100-500000: 1.
8. The method for the asymmetric hydrogenation of imines catalyzed by an iridium/chiral diphosphine system according to claim 1 or 2, wherein: the preparation method of the chiral diphosphine ligand L comprises the following steps:
(1) introducing argon to react (R)c,Sp) -ppfa (i) and imidazole are dissolved in dehydroacetic acid and heated to 80 ℃ for 8 hours; (R)c,Sp) The molar ratio of PPFA (I) to imidazole is 1: 1.1-5;
After cooling, neutralizing with an excess saturated sodium bicarbonate solution, extracting with dichloromethane (3 × 50ml), combining organic phases, washing with saturated brine, drying over anhydrous sodium sulfate, removing the solvent, and subjecting the crude product to column chromatography (n-hexane/ethyl acetate/triethylamine ═ 10/10/1) to obtain brown crystals II;
(2) under the condition of introducing argon, dissolving the brown crystal II in diethyl ether, slowly dropwise adding n-BuLi, gradually changing the reaction mixture into a dark red clear solution, and continuously reacting for one hour; dropwise adding diphenyl phosphine chloride, wherein the molar ratio of the brown crystal II, the n-BuLi and the diphenyl phosphine chloride is 1: 1.2-5;
After reacting for two hours, a saturated sodium hydrogencarbonate solution was added, and the organic phase was separated, washed with saturated brine and dried over anhydrous sodium sulfate. Desolventizing, column chromatography (n-hexane/ethyl acetate 10/1), and n-hexane recrystallization to give 0.24g of orange needle crystals IaNamely chiral diphosphine ligand L.
CN201810547260.9A 2018-05-31 2018-05-31 Method for catalyzing asymmetric hydrogenation of imine by iridium/chiral diphosphine system Active CN110551037B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810547260.9A CN110551037B (en) 2018-05-31 2018-05-31 Method for catalyzing asymmetric hydrogenation of imine by iridium/chiral diphosphine system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810547260.9A CN110551037B (en) 2018-05-31 2018-05-31 Method for catalyzing asymmetric hydrogenation of imine by iridium/chiral diphosphine system

Publications (2)

Publication Number Publication Date
CN110551037A true CN110551037A (en) 2019-12-10
CN110551037B CN110551037B (en) 2021-11-09

Family

ID=68734340

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810547260.9A Active CN110551037B (en) 2018-05-31 2018-05-31 Method for catalyzing asymmetric hydrogenation of imine by iridium/chiral diphosphine system

Country Status (1)

Country Link
CN (1) CN110551037B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112142784A (en) * 2020-10-12 2020-12-29 南方科技大学 Asymmetric reduction of nitrogen-phosphono-protected imines
CN112824424A (en) * 2019-11-21 2021-05-21 中国科学院大连化学物理研究所 Chiral ferrocene-imidazole diphosphine ligand and synthesis method and application thereof
CN112824373A (en) * 2019-11-21 2021-05-21 中国科学院大连化学物理研究所 Method for preparing chiral amine by iridium-catalyzed asymmetric hydrogenation of imine
CN114669333A (en) * 2022-04-25 2022-06-28 中山大学 Catalyst system and method for catalyzing decarbonylation and hydrogenation of alpha-quaternary carbon aldehyde
CN115806493A (en) * 2022-12-09 2023-03-17 南京工业大学 Method for synthesizing chiral ebavir intermediate by asymmetric hydrogenation
CN116082268A (en) * 2023-01-13 2023-05-09 天津大学 Chiral benzomorpholine compound and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101857612A (en) * 2010-06-11 2010-10-13 南京工业大学 Chiral diphosphite ligand and iridium composite catalyst and preparation thereof method and application to asymmetrical hydrogenization synthesis (S)-metolachlor
CN102006930A (en) * 2008-04-17 2011-04-06 联合磷业有限公司 Hydrogenation of imines
CN102950024A (en) * 2011-08-23 2013-03-06 中国中化股份有限公司 Catalyst for asymmetric catalytic hydrogenation of imine
CN102950025A (en) * 2011-08-23 2013-03-06 中国中化股份有限公司 Asymmetric hydrogenation catalyst of imine and its use
CN102951980A (en) * 2011-08-23 2013-03-06 中国中化股份有限公司 Asymmetric catalytic hydrogenation method of imine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102006930A (en) * 2008-04-17 2011-04-06 联合磷业有限公司 Hydrogenation of imines
CN101857612A (en) * 2010-06-11 2010-10-13 南京工业大学 Chiral diphosphite ligand and iridium composite catalyst and preparation thereof method and application to asymmetrical hydrogenization synthesis (S)-metolachlor
CN102950024A (en) * 2011-08-23 2013-03-06 中国中化股份有限公司 Catalyst for asymmetric catalytic hydrogenation of imine
CN102950025A (en) * 2011-08-23 2013-03-06 中国中化股份有限公司 Asymmetric hydrogenation catalyst of imine and its use
CN102951980A (en) * 2011-08-23 2013-03-06 中国中化股份有限公司 Asymmetric catalytic hydrogenation method of imine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DORTA, ROMANO等: "Chiral xyliphos complexes for the catalytic imine hydrogenation leading to the metolachlor herbicide: Isolation of catalyst-substrate adducts", 《CHEMISTRY-A EUROPEAN JOURNAL》 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112824424A (en) * 2019-11-21 2021-05-21 中国科学院大连化学物理研究所 Chiral ferrocene-imidazole diphosphine ligand and synthesis method and application thereof
CN112824373A (en) * 2019-11-21 2021-05-21 中国科学院大连化学物理研究所 Method for preparing chiral amine by iridium-catalyzed asymmetric hydrogenation of imine
CN112824424B (en) * 2019-11-21 2022-07-15 中国科学院大连化学物理研究所 Chiral ferrocene-imidazole diphosphine ligand and synthesis method and application thereof
CN112142784A (en) * 2020-10-12 2020-12-29 南方科技大学 Asymmetric reduction of nitrogen-phosphono-protected imines
CN112142784B (en) * 2020-10-12 2022-06-17 南方科技大学 Asymmetric reduction of nitrogen-phosphono-protected imines
CN114669333A (en) * 2022-04-25 2022-06-28 中山大学 Catalyst system and method for catalyzing decarbonylation and hydrogenation of alpha-quaternary carbon aldehyde
CN114669333B (en) * 2022-04-25 2023-06-23 中山大学 Catalyst system and catalytic method for catalyzing decarbonylation hydrogenation of alpha-quaternary carbon aldehyde
CN115806493A (en) * 2022-12-09 2023-03-17 南京工业大学 Method for synthesizing chiral ebavir intermediate by asymmetric hydrogenation
CN115806493B (en) * 2022-12-09 2024-03-22 南京工业大学 Method for synthesizing epstein chiral intermediate by asymmetric hydrogenation
CN116082268A (en) * 2023-01-13 2023-05-09 天津大学 Chiral benzomorpholine compound and preparation method thereof
CN116082268B (en) * 2023-01-13 2024-03-19 天津大学 Chiral benzomorpholine compound and preparation method thereof

Also Published As

Publication number Publication date
CN110551037B (en) 2021-11-09

Similar Documents

Publication Publication Date Title
CN110551037B (en) Method for catalyzing asymmetric hydrogenation of imine by iridium/chiral diphosphine system
CN110548546A (en) Method for catalyzing asymmetric hydrogenation of imine by iridium/linear phosphine-phosphoramidite system
CN103570484A (en) Asymmetric hydrogenation synthetic method of chiral aromatic amine compound with high steric hindrance
Dai et al. Ionic-salt-tagged ferrocenyl diphosphine–imine ligands and their application to palladium-catalyzed asymmetric allylic etherification
CN109422603A (en) A kind of method of iridium catalysis asymmetric hydrogenation imines synthesis of chiral amine compounds
CN110551036B (en) Iridium/chiral phosphite ester-pyridine catalyzed imine asymmetric hydrogenation method
CN105017150B (en) A kind of method of the outer amine of the amine asymmetric hydrogenation synthesis of chiral ring of palladium chtalyst quinoline 3
Tari et al. Enantioselective Michael reaction of β-keto esters organocatalyzed by recoverable Cinchona-derived dimeric ammonium salts
CN110551035A (en) Iridium-catalyzed asymmetric reductive amination method for ketone
Ueda et al. A new class of C2 chiral photodimer ligands for catalytic enantioselective diethylzinc addition to arylaldehydes
Ferretti et al. Unexpected coordination behavior of ruthenium to a polymeric α-diimine containing the poly [bis (arylimino) acenaphthene] fragment
CN111285775B (en) Method for applying fructose-derived pyridine alcohol chiral ligand to asymmetric reductive amination of ketone
EP3609859B1 (en) Chiral metal complex compounds
CN112824424B (en) Chiral ferrocene-imidazole diphosphine ligand and synthesis method and application thereof
CN111285770B (en) Asymmetric reductive amination method based on fructose-derived chiral monodentate phosphite ligand ketone
CN111285773A (en) Method for preparing chiral amine based on glucose-derived monodentate phosphite ligand asymmetric hydrogenation
CN111285774A (en) Asymmetric imine hydrogenation method based on chiral monodentate phosphine ligand derived from D-mannitol
CN112824374B (en) Method for preparing chiral amine compound by asymmetric hydrogenation of nickel catalytic imine
CN112824375B (en) Method for preparing chiral amine compound by palladium-catalyzed asymmetric hydrogenation of imine
CN112279743B (en) Synthesis method of chiral alpha-amino acid ester derivative
JPWO2002055477A1 (en) Method for producing ruthenium compound, diamine compound and β-amino alcohol
US9340519B2 (en) Paracyclophane-based ligands, their preparation and use in catalysis
CN110551033B (en) Method for preparing chiral amine through asymmetric reductive amination of ketone
CN110551034B (en) Asymmetric reductive amination method of ketone
CN110551032B (en) Asymmetric reductive amination method for catalyzing ketone by iridium chiral phosphine-aminophosphine ligand system

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant